Treatment Of Ophthalmic Conditions With Son of Sevenless 2 (SOS2) Inhibitors

Novel Structurally Designed shRNAs

CONJUGATED OLIGONUCLEOTIDE COMPOUNDS, METHODS OF MAKING AND USES THEREOF

Anti-PVRIG antibodies and methods of use

NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS

Method of Treating Corneal Opacities and Scarring

METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS

ARTIFICIALLY SYNTHESIZED SPHINGOSINE DERIVATIVE LIPOID MONOMER AND USE OF SAME FOR DELIVERING NUCLEIC ACID

TRPC3 AS A THERAPEUTIC TARGET FOR ALZHEIMER’S DISEASE

HAPLOID INDUCTION COMPOSITIONS AND METHODS FOR USE THEREFOR

Suppression-Replacement Gene Therapy

COMPOSITIONS AND METHODS FOR IMPROVING IMMUNE SYSTEM FUNCTION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE

IL-34 antisense agents and methods of using same

MODIFIED T CELLS FOR ADOPTIVE IMMUNOTHERAPY

NOVEL LIGANDS FOR ASIALOGLYCOPROTEIN RECEPTOR

COMPOSITIONS FOR THE TREATMENT OF EBV ASSOCIATED DISEASES OR CONDITIONS

Heterocyclic carboxylate compounds as glycolate oxidase inhibitors

FIBROTIC TREATMENT

LOCALIZED THERAPY OF LOWER AIRWAYS INFLAMMATORY DISORDERS WITH PROINFLAMMATORY CYTOKINE INHIBITORS

RNAi TARGETING OF FUNGAL PATHOGEN TETRASPANIN PROTEINS

RNAI CONSTRUCTS AND METHODS FOR INHIBITING FAM13A EXPRESSION

DRUG DELIVERY COMPOSITION, METHOD FOR PRODUCING SAME AND USE THEREOF

CONJUGATED OLIGONUCLEOTIDES

GENETICALLY-MODIFIED IMMUNE CELLS COMPRISING A MICRORNA-ADAPTED SHRNA (SHRNAMIR)

METHODS AND COMPOSITIONS UTILIZING IDO1-DEPENDENT VASCULARIZING CELLS FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS INVOLVING NEOVASCULARIZATION

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

GENE SILENCING THERAPY OF ACUTE RESPIRATORY DISORDER

TOXIC RNAi ACTIVE SEED SEQUENCES FOR KILLING CANCER CELLS

RAAV-BASED COMPOSITIONS AND METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

REGULATORY ELEMENTS FOR SCHWANN CELL-SPECIFIC GENE EXPRESSION

FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

ENGINEERED NK CELLS AND METHODS OF TREATING CANCER

ROR2 INHIBITORS AND USE THEREOF IN TREATING AND/OR PREVENTING CARTILAGE LOSS

COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS

METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS

METHOD OF ALLELE SPECIFIC SILENCING FOR THE TREATMENT OF AUTOSOMAL DOMINANT CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT)

Target Ligand

Methods to Quantify Rate of Clonal Expansion and Methods for Treating Clonal Hematopoiesis and Hematologic Malignancies

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

Muscle targeting complexes and uses thereof for treating dystrophinopathies

NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES

Lipid compositions

COMPOSITIONS AND METHODS FOR SILENCING KRAS

COMPOSITIONS AND METHODS TO TREAT CANCER

COMPOSITIONS AND METHODS FOR CHARACTERIZING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH MULTIPLE ORGAN FAILURE

ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR THE TREATMENT OF PAIN

DOUBLE STRANDED RNA TARGETING ANGIOTENSINOGEN (AGT) AND METHODS OF USE THEREOF

OLIGONUCLEOTIDES FOR PMS1 MODULATION

COMPOSITIONS AND METHODS FOR CONTROLLING PSYLLIDS

COMPOSITIONS AND METHODS FOR TREATING BETA-HEMOGLOBINOPATHIES

FN3 Domain-siRNA Conjugates with Enzyme Replacement Therapy

Medicine Containing USAG-1-Targeting RNA Molecule for Tooth Regeneration Therapy

IHH AS A BIOMARKER AND THERAPEUTIC TARGET FOR NONALCOHOLIC STEATOHEPATITIS (NASH)

Lipids and compositions for the delivery of therapeutics

RNAi APPROACH FOR CROP PEST PROTECTION

CELL PENETRATING PEPTIDE MEDIATED RNA TRANSDUCTION WITHIN INSECT CELLS

PREVENTION AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION THROUGH SUPPRESSION OF CATHEPSIN S EXPRESSION

RNA COMPOSITIONS AND METHODS FOR INHIBITING LIPOPROTEIN(A)

COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF

METHODS AND COMPOSITIONS FOR NUCLEIC ACID AND PROTEIN PAYLOAD DELIVERY

COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION

INTERFERING RNAS TARGETING SEVERE ACUTE RESPIRATORY SYNDROME-ASSOCIATED CORONAVIRUS AND USES THEREOF FOR TREATING COVID-19

PVRIG POLYPEPTIDES AND METHODS OF TREATMENT

LIPID NANOPARTICLE

ANTI-FIBROTIC COMPOSITIONS COMPRISING FENDRR OR FRAGMENTS OR VARIANTS THEREOF AND METHODS OF PRODUCTION AND USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING EPILEPSY

GALNAC COMPOSITIONS FOR IMPROVING SIRNA BIOAVAILABILITY

Compositions and methods comprising engineered short nuclear RNA (snRNA)

COMPOSITION CONTAINING NUCLEIC ACID MOLECULE STABLY

MEDIATORS OF GENE SILENCING

METHODS RELATING TO CIRCULATING TUMOR CELL CLUSTERS AND THE TREATMENT OF CANCER

SNCA IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING SNCA-ASSOCIATED NEURODEGENERATIVE DISEASES

TREATMENTS FOR RETINAL DEGENERATIVE DISEASES

METHODS AND COMPOSITIONS FOR WOUND HEALING

Extrahepatic delivery

Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS6) expression

DOUBLE STRANDED RNA TARGETING 17-BETA HYDROXYSTEROIDDEHYDROGENASE 13 (HSD17B13) AND METHODS OF USE THEREOF

SIRT1-saRNA Compositions and Methods of Use

COMPOSITIONS AND METHODS FOR SUPPRESSING MSUTZ

CASP8AP2 ANTAGONISTS FOR USE IN THE PREVENTION OR TREATMENT OF CANCER

COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS

COMPOSITIONS AND METHODS FOR INHIBITING OR SCREENING FOR CD8 AND METHODS AND ASSAYS FOR DETECTING CD8 IN CELLS

COMPOSITIONS AND METHODS OF TREATING FANCONI ANEMIA

Compositions and methods for nanoparticle lyophile forms

ENHANCED NANOPARTICLE DELIVERY SYSTEMS

MODULATION OF GENE EXPRESSION AND SCREENING FOR DEREGULATED PROTEIN EXPRESSION

SINA MOLECULES, METHODS OF PRODUCTION AND USES THEREOF

CHEMICAL MODIFICATIONS FOR INHIBITING EXPRESSION OF ALDH2

MATERIALS AND METHODS FOR TREATING CORNEAL DYSFUNCTION

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

IMMUNO-ONCOLOGY TARGETS TO IMPROVE T-CELL METABOLIC RESPONSE

METHODS AND COMPOSITIONS FOR INCREASED DOUBLE STRANDED RNA PRODUCTION

COMPOSITIONS AND METHODS FOR INHIBITING SNCA EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING MAPT EXPRESSION

COMPOSITIONS TARGETING PACS1 AND METHODS OF USE THEREOF

B-SPECTRIN (SPTBN1) DEFICIENCY PROTECTS MICE FROM HIGH-FAT DIET-INDUCED LIVER DISEASE AND CANCER DEVELOPMENT

RNAi Agents for Inhibiting Expression of DUX4, Compositions Thereof, And Methods of Use

OLIGONUCLEOTIDES FOR ATN1 MODULATION

DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO

INTEGRIN TARGETING LIGANDS AND USES THEREOF

METHODS AND COMPOSITIONS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

NUCLEIC ACIDS CONTAINING ABASIC NUCLEOTIDES

CONDITIONAL-SIRNAS AND USES THEREOF IN TREATING ACUTE MYELOID LEUKEMIA

TREATMENT OF SOS2 RELATED DISEASES AND DISORDERS

USE OF FcgammaRIII INHIBITOR IN PREPARATION OF MEDICAMENT FOR TREATING PULMONARY FIBROSIS

GENE THERAPY FOR ALZHEIMER'S DISEASE

PREVENTION AND/OR TREATMENT OF HEARING LOSS OR IMPAIRMENT

EXOSOMAL LOADING USING HYDROPHOBICALLY MODIFIED OLIGONUCLEOTIDES

COMPOSITIONS AND METHODS OF TREATING MUSCLE DYSTROPHY

SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19

G PROTEIN-COUPLED RECEPTOR 75 (GPR75) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING PRIMARY HYPEROXALURIA

TARGETED NUCLEIC ACID THERAPY FOR HEPATITIS B

Huntingtin (HTT) iRNA agent compositions and methods of use thereof

NUCLEIC ACID MOLECULES WITH INCREASED GENE SILENCING ACTIVITY AND USES THEREOF

COMPOSITION FOR TREATING RETINAL OR CHOROIDAL DISEASES, CONTAINING ACTA2 INHIBITOR AS ACTIVE INGREDIENT

VARIANT RNAi

REDUCING BETA-CATENIN EXPRESSION TO POTENTIATE IMMUNOTHERAPY

MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN

PROMOTING NUTRIENT ABSORPTION THROUGH THE COLON

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS FOR PRODUCTION OF MSC-DERIVED EXOSOMES

SIRNA, MEDICAL COMPOSITIONS, AND METHODS FOR TREATING DIABETES USING THE SAME

Methods and Compositions for Reducing Immunosupression by Tumor Cells

NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL3

TARGETING XIST AND RNA METHYLATION FOR X REACTIVATION THERAPY

PLATELETS AS DELIVERY AGENTS

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

POLYMERS AND NANOPARTICLE FORMULATIONS FOR SYSTEMIC NUCLEIC ACID DELIVERY

COMPOSITIONS AND METHODS FOR MODULATION OF BACTERIAL GENE EXPRESSION

Markers selectively deregulated in tumor-infiltrating regulatory T cells

COMPOSITIONS AND METHODS FOR MODULATING SCAP ACTIVITY

COMPOUNDS AND METHODS FOR MODULATING PMP22

MARF/MFN MODULATORS AND USES THEREOF

NOVEL COMPOUND AND APPLICATION THEREOF

OLIGONUCLEIC ACID CONJUGATE

ENDOSOMAL ESCAPE DOMAINS FOR DELIVERY OF MACROMOLECULES INTO CELLS

METHODS FOR X CHROMOSOME REACTIVATION

Methods of treating cholangiocarcinoma

SIRT1 INHIBITOR OR ANTAGONIST FOR USE IN PREVENTING AND/OR TREATING AN HPV INDUCED TUMOUR

POLYMER NANOPARTICLE, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD FOR INTRACELLULAR DELIVERY OF A CARGO

LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

COMPOSITIONS AND METHODS FOR INHIBITING GYS2 EXPRESSION

FATS AS A TARGET FOR TREATING TUMORS AND USES THEREOF

5-HALOURACIL-MODIFIED MICRORNAS AND THEIR USE IN THE TREATMENT OF CANCER

Modified short interfering nucleic acid (siNA) molecules and uses thereof

METHODS FOR INDUCING ADIPOSE TISSUE REMODELING USING RNAI THERAPEUTICS

ABCD1 FOR TREATMENT OF NEURODISORDERS

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

PROTECTION FROM OVARIAN FAILURE BY LOW DOSE INTERLEUKIN-2 ADMINISTRATION

COMPOUNDS AND METHODS FOR REDUCING IFNAR1 EXPRESSION

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

p21 mRNA target areas for silencing

COMPOUNDS AND METHODS FOR REDUCING APOE EXPRESSION

ANTI-IDIOTYPE COMPOSITIONS AND METHODS OF USE THEREOF

Nucleic acid, composition and conjugate containing same, preparation method, and use thereof

RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION

SYSTEMS, METHODS AND COMPOSITION OF USING RNASE III MUTANTS TO PRODUCE SRNA TO CONTROL HOST PATHOGEN INFECTION

METHODS AND COMPOSITIONS FOR TREATING CANCER

METHODS AND APPARATUSES FOR BIOMOLECULE DELIVERY TO PRIMARY HUMAN HEMATOPOIETIC STEM CELLS USING NANOSTRAWS

METHODS FOR THE REDUCTION OF Z-AAT PROTEIN LEVELS

SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS

REDUCING FRATRICIDE OF IMMUNE CELLS EXPRESSING NKG2D-BASED RECEPTORS

METHODS FOR DE-CLOAKING CANCER FROM THE IMMUNE SYSTEM THROUGH DOWNREGULATION OF CANCER-PRODUCED PREGNANCY SPECIFIC GLYCOPROTEIN

THERAPEUTIC AGENTS AND USES THEREOF

RNA-BASED CONTROL OF LEPIDOPTERAN PESTS

METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS

Plastid-transgene-encoded nuclear gene silencing

SIRNA SEQUENCE FOR EFFECTIVELY INHIBITING EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR

COMPOSITIONS AND METHODS FOR INHIBITING MITOCHONDRIA AMIDOXIME REDUCING COMPONENT 1 (MARC1) EXPRESSION

DOUBLE-STRANDED RNA THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN AND PHARMACEUTICAL COMPOSITION

MAPT RNA interference agents

Compositions and methods of treating facioscapulohumeral muscular dystrophy

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

Gene-regulating compositions and methods for improved immunotherapy

METHODS OF TREATMENT OF INFLAMMATORY BOWEL DISEASES

THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS

Delivery of hydrophobic active agent particles

VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER

NOVEL USE OF HIC-5 INHIBITOR

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

PHARMACEUTICAL COMPOSITION CONTAINING SIRT7 INHIBITOR FOR PREVENTING OR TREATING ALLERGIC DISEASES

Amphiregulin gene-specific double-stranded oligonucleotide and composition for preventing and treating fibrosis-related diseases and respiratory diseases, comprising same

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

DISCONTINUOUS OLIGONUCLEOTIDE LIGANDS

IRNA COMPOSITIONS AND METHODS FOR SILENCING GROWTH FACTOR RECEPTOR BOUND PROTEIN 10 (GRB10) OR GROWTH FACTOR RECEPTOR BOUND PROTEIN 14 (GRB14) IN THE LIVER

Treatment of amyotrophic lateral sclerosis (ALS)

Ketohexokinase (KHK) iRNA compositions and methods of use thereof

COMPLEMENT COMPONENT C1R INHIBITORS FOR TREATING A NEUROLOGICAL DISEASE, AND RELATED COMPOSITIONS, SYSTEMS AND METHODS OF USING SAME

COMPOSITION AND USE OF siRNAs AGAINST VEGFR2 AND TGF-BETA1 IN COMBINATION THERAPY FOR CANCER

TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6 (TRAF6) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER METASTASIS

ANTIVIRAL SILENCING RNA MOLECULES, CHEMICALLY MODIFIED ANTIVIRAL SILENCING RNA MOLECULES WITH ENHANCED CELL PENETRATING ABILITIES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND USES THEREOF FOR TREATMENT OF VIRAL INFECTIONS

ANTISENSE RNA FOR TREATMENT OF SARS-ASSOCIATED CORONAVIRUS

RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)

Compositions and Methods of Treatment

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

TARGETING OF LACTATE DEHYDROGENASE C, METHODS OF PREPARING SAME, AND METHODS OF USING SAME IN COMBINATION WITH ANTI-CANCER TREATMENTS

MONOCLONAL ANTIBODIES TO CHEMICALLY-MODIFIED NUCLEIC ACIDS AND USES THEREOF

OLIGONUCLEOTIDES FOR MLH3 MODULATION

IN VIVO LYMPHOVENOUS ANASTOMOSIS

METHODS FOR THE TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MSH3 ACTIVITY

SYSTEMS AND METHODS FOR IDENTIFYING CELLS THAT HAVE UNDERGONE GENOME EDITING

EPHB2 ANTIBODY AND USE THEREOF IN COMBINATION THERAPY

COMPOSITIONS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS

CORNEAL ENDOTHELIUM ECM THERAPEUTIC MEDICAMENTS

MIRNA-485 INHIBITOR FOR HUNTINGTON'S DISEASE

MUSCLE REGENERATION AND GROWTH

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS

Modified oligonucleotides

ANTI-SEED PNAS AND MICRORNA INHIBITION

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES

MODIFIED LYMPHOCYTES

ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN STRIATAL NEURONS

RNAS for complement inhibition

METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINOPATHY AND OTHER OCULAR DISEASES

LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR

Compositions and methods for mitigating pest infestation

CORONAVIRUS-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDES, AND COMPOSITION COMPRISING SAME FOR PREVENTING AND TREATING CORONAVIRUS DISEASE-19

METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION

GalNAc compositions for improving siRNA bioavailability

RNA MOLECULE, CHIMERIC NA MOLECULE, DOUBLE-STRANDED RNA MOLECULE, AND DOUBLE-STRANDED CHIMERIC NA MOLECULE

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS

CYSTIC LYMPHANGIOMA TREATMENT DRUG

METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH HUMAN CYTOMEGALOVIRUS

IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY

MICRORNA AND USES THEREOF IN PREVENTION AND/OR TREATMENT OF FIBROPLASIA MEDICAL SIGN AND/OR SYNDROME

METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS

G PROTEIN-COUPLED RECEPTOR 146 (GPR146) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

USE OF PI3KC2B INHIBITORS FOR THE PRESERVATION OF VASCULAR ENDOTHELIAL CELL BARRIER INTEGRITY

COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL3 EXPRESSION

RNAi COMPOSITIONS AND METHODS OF USE THEREOF FOR DELIVERY BY INHALATION

MAGNETIC INORGANIC IRON-BASED NANOPARTICLES

Compositions and methods of treating facioscapulohumeral muscular dystrophy

MODIFIED SIRNA WITH REDUCED OFF-TARGET ACTIVITY

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES

KRAB FUSION REPRESSORS AND METHODS AND COMPOSITIONS FOR REPRESSING GENE EXPRESSION

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

NUCLEIC ACID LIGAND CONJUGATES AND USE THEREOF FOR DELIVERY TO CELLS

Treatment delivery system and method

Compositions and methods for treatment of sepsis-related disorders

COMPOSITIONS AND METHODS FOR TRANSDIFFERENTIATING CELLS

Compositions and methods for controlling food intake of animal

Bone Morphogenetic Protein-8B (BMP8B) as marker and therapeutic target for liver fibrosis or liver cancer

METHOD FOR THE PRODUCTION OF DOUBLE-STRANDED RNA

Methods Of Treating Headaches And Migraines With Sodium Voltage-Gated Channel Alpha Subunit 11 (SCN11A) Inhibitors

COMPOSITIONS AND METHODS COMPRISING ENGINEERED SHORT NUCLEAR RNA (SNRNA)

Compositions and methods of treating Facioscapulohumeral muscular dystrophy

ORTHOGONALLY LINKED MULTIMERIC OLIGONUCLEOTIDES

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

Methods of Prevention or Treatment of Alzheimer's Disease by Blocking or Decreasing STING Signaling Activation

METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS

SMALL RNA MEDICAMENT FOR PREVENTION AND TREATMENT OF INFLAMMATION-RELATED DISEASES AND COMBINATION THEREOF

COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF

ENGINEERED MICROALGAE FEED TO IMPROVE HONEY BEE PATHOGEN RESISTANCE AND NUTRITION

RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX

Compositions and methods for modulating APOC3 expression

COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION

AGENT FOR PREVENTING OR TREATING MUSCULAR DISEASE

siRNAs WITH VINYLPHOSPHONATE AT THE 5' END OF THE ANTISENSE STRAND

COMPLEMENT COMPONENT C3 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING COMPLEMENT COMPONENT C3-ASSOCIATED DISEASES

Muscle targeting complexes and uses thereof for treating dystrophinopathies

Compositions and methods for treating hyperphagia in prader-willi syndrome

Compositions and methods for reducing skin fat

COMBINATORIAL INHIBITION OF TRANSCRIPTION FACTORS FOR TREATMENT OF HEART FAILURE

RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use

COMPOSITION COMPRISING OSTEOPONTIN INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF NEURODEGENERATIVE DISEASE

GENE CONSTRUCTS FOR SILENCING ANGIOPOIETIN-LIKE 3 (ANGPTL3) AND USES THEREOF

SMAC/Diablo inhibitors useful for treating cancer

RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use

Treatment of Genetic Dilated Cardiomyopathies

Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) Inhibitors

PRODUCTS AND COMPOSITIONS

METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF ARGININOSUCCINATE SYNTHETASE (ASS1)

SIRNA OF ANGPTL3 AND USE THEREOF

Circular siRNAs

Compositions and methods for inhibiting expression of transthyretin

MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT

METHODS FOR TREATING GLIOBLASTOMA

Use of Paperclip RNA Structure to Inhibit Target Gene Expression

Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors

RESPIRATORY SYNCYTIAL VIRUS (RSV) POLYANHYDRIDE NANOPARTICLE VACCINE

Composition for regulating expression of PROX1 or expression of telomerase reverse transcriptase comprising activity regulator or method for screening telomerase reverse transcriptase regulator

Lipid formulations for delivery of therapeutic agents

T-CELLS EXPRESSING IMMUNE CELL ENGAGERS IN ALLOGENIC SETTINGS

INTERFERON- INDUCING OLIGONUCLEOTIDE DUPLEXES AND METHODS OF USE

PLURIPOTENT STEM CELL AND DERIVATIVE THEREOF

Composition, Comprising Rip Kinase Inhibitor, For Preventing Hair Loss Or Promoting Hair Regrowth

NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS

HOST DEFENSE SUPPRESSING METHODS AND COMPOSITIONS FOR MODULATING A GENOME

CONJUGATE OF DOUBLE-STRANDED SIRNA ANALOGUE

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR DISEASES

ARGONAUTE PROTEIN FROM EUKARYOTES AND APPLICATION THEREOF

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE

INHIBITION OF BMI1 ELIMINATES CANCER STEM CELLS AND ACTIVATES ANTITUMOR IMMUNITY